相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Remote Monitoring in Idiopathic Pulmonary Fibrosis: Home Is Where the Bluetooth-enabled Spirometer Is
Kerri A. Johannson
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis A Randomized Controlled Trial
Catharina C. Moor et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic
Alyson W. Wong et al.
CHEST (2020)
Mobile Health Monitoring in Patients with Idiopathic Pulmonary Fibrosis
Veronica Marcoux et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2019)
Role of a Regional Multidisciplinary Conference in the Diagnosis of Interstitial Lung Disease
Japnam S. Grewal et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2019)
Daily home spirometry to detect early steroid treatment effects in newly treated pulmonary sarcoidosis
Caroline E. Broos et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Home monitoring improves endpoint efficiency in idiopathic pulmonary fibrosis
Kerri A. Johannson et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis
Julie Morisset et al.
CHEST (2017)
Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary Fibrosis
Anne-Marie Russell et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
The Canadian Registry for Pulmonary Fibrosis: Design and Rationale of a National Pulmonary Fibrosis Registry
Christopher J. Ryerson et al.
CANADIAN RESPIRATORY JOURNAL (2016)
Are differences in travel time or distance to healthcare for adults in global north countries associated with an impact on health outcomes? A systematic review
Charlotte Kelly et al.
BMJ OPEN (2016)
Predicting Survival Across Chronic Interstitial Lung Disease The ILD-GAP Model
Christopher J. Ryerson et al.
CHEST (2014)
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Rituximab in severe, treatment-refractory interstitial lung disease
Gregory J. Keir et al.
RESPIROLOGY (2014)
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
William D. Travis et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation
Martijn A. Spruit et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Novel use of rituximab in hypersensitivity pneumonitis refractory to conventional treatment
Harpreet K. Lota et al.
THORAX (2013)
A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis
Brett Ley et al.
ANNALS OF INTERNAL MEDICINE (2012)
An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
分享论文
